| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.16 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |